Our findings highlight the role of FXR in hepatocytes in the pathogenesis of NASH and demonstrate the anti-fibrotic effect of OCA in a unique murine model of NASH with obesity and insulin resistance. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.